Verve Therapeutics Inc (VERV)

34.16 +0.91  +2.74% NASDAQ Nov 30, 16:00 34.16 0.00  0.00% After-Hours: 18:29 USD

Verve Therapeutics Debt to Equity Ratio

View 4,000+ financial data types
View Full Chart

Debt to Equity Ratio Chart

Export Data
Save Image
Print Image

Historical Debt to Equity Ratio Data

View and export this data going back to 1962. Start your Free Trial
Export Data Date Range:
Data for this Date Range  

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Benchmarks

Regenxbio Inc 0.00
Krystal Biotech Inc --
Beam Therapeutics Inc 0.0068

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 410.88M
Total Liabilities (Quarterly) 25.94M
Shareholders Equity (Quarterly) 384.94M


Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.